Categories: News

Cowen to Hold Conference Call to Discuss Fourth Quarter 2020 Financial Results

NEW YORK, Jan. 12, 2021 (GLOBE NEWSWIRE) — Cowen Inc. (NASDAQ:COWN) (“Cowen” or the “Company”) will host a conference call on Thursday, February 11, 2021 at 9:00 AM ET to discuss the Company’s financial results for the fourth quarter of 2020.

The conference call will be broadcast live via this link on the Investor Relations section of Cowen’s website. Please access the link at least 15 minutes prior to the call to register. A replay will be available on the Investor Relations section of Cowen’s website approximately two hours after completion of the conference call at investor.cowen.com/investor-calls.

Investors can also access the conference call by dialing 1-855-760-0961 (1-631-485-4850 outside the U.S.). The passcode for the call is 9894979. A recording of the conference call will be available for one week beginning at 12:00 PM ET on February 11 by dialing 1-855-859-2056 (1-404-537-3406 outside the U.S.) and entering passcode 9894979.

About Cowen Inc.
Cowen Inc. (“Cowen” or the “Company”) is a diversified financial services firm offering investment banking services, equity and credit research, sales and trading, prime brokerage, global clearing, commission management services and actively managed alternative investment products. Cowen Inc. focuses on delivering value-added capabilities to our clients in order to help them outperform. Founded in 1918, the firm is headquartered in New York and has offices worldwide. Learn more at Cowen.com.

Investor Relations Contact:
Cowen Inc.
J.T. Farley
1-646-562-1056
james.farley@cowen.com

Staff

Recent Posts

Health Care AI Initiative Launched by Paragon Health Institute

New initiative will promote AI policies and solutions to transform American health careWASHINGTON, Jan. 12,…

45 minutes ago

Amphastar Pharmaceuticals Announces Exclusive License Agreement with Nanjing Hanxin Pharmaceutical Technology Co., Ltd. for Fully Synthetic Corticotropin Compound

Agreement expands Amphastar's proprietary peptide pipeline into broader inflammatory and autoimmune conditions RANCHO CUCAMONGA, CA…

45 minutes ago

CelLBxHealth PLC Announces Board Changes

GUILDFORD, SURREY / ACCESS Newswire / January 12, 2026 / CelLBxHealth plc (AIM:CLBX), a leader…

4 hours ago

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

5 hours ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

19 hours ago